Attenuated vaccines are a type of vaccine that involves using weakened forms of live pathogens to stimulate an immune response without causing the disease. These vaccines are created by modifying the pathogen in a way that it loses its virulence or disease-causing ability while retaining its immunogenicity. The weakened pathogen in the vaccine can still replicate within the body, leading to a robust and long-lasting immune response. Common examples of attenuated vaccines include the measles, mumps, and rubella (MMR) vaccine, the oral polio vaccine (OPV), and the yellow fever vaccine. Attenuated vaccines often provide strong and durable immunity with just one or a few doses. While effective, attenuated vaccines may not be suitable for individuals with weakened immune systems, as the weakened pathogen could pose a risk. Additionally, careful handling and storage are crucial to maintaining the vaccine's viability. Despite these considerations, attenuated vaccines have played a pivotal role in preventing a range of infectious diseases, contributing significantly to global public health efforts.
Submit your abstract Today
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan